Beam Therapeutics Inc. Capex/Depreciation

Capex/Depreciation of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending September 30, 2022 was -46.04 (a 477.99% increase compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation increased by 790.96%
  • Annual Capex/Depreciation for 2021 was -6.35 (a 88.29% increase from previous year)
  • Annual Capex/Depreciation for 2020 was -3.37 (a -30.45% decrease from previous year)
  • Annual Capex/Depreciation for 2019 was -4.85 (a -76.0% decrease from previous year)
  • Twelve month Capex/Depreciation ending September 30, 2022 was -6.37 (a 31.98% increase compared to previous quarter)
  • Twelve month trailing Capex/Depreciation increased by 0.43% year-over-year
Trailing Capex/Depreciation for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
-6.37 -4.83 -4.79 -6.35
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of Beam Therapeutics Inc.

Most recent Capex/Depreciationof BEAM including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of Beam Therapeutics Inc.

Beam Therapeutics Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -46.04 -7.97 -2.48
2021 -5.17 -3.35 -9.8 -8.12 -6.35
2020 -6.06 -2.06 -2.02 -3.14 -3.37
2019 -2.87 -2.49 -12.52 -3.2 -4.85
2018 -20.19 -20.19
2017 0.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology